RobertMGrossbergMD
Infectious Disease • Bronx, NYHIV/AIDS Medicine, Mycobacterial Disease
Professor, Medicine, Infectious Diseases, Albert Einstein College of Medicine
Dr. Grossberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MMC Dept of Medicine
111 East 210TH Street
Bronx, NY 10467Phone+1 718-920-5224Fax+1 718-405-0610
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 1999 - 2001- University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
The Warren Alpert Medical School of Brown UniversityClass of 1996
Certifications & Licensure
NY State Medical License 2004 - 2025
PA State Medical License 1997 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment Start of enrollment: 2012 Jun 01
- Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV Start of enrollment: 2015 Aug 01
- Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1 Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- 15 citationsOral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental PatientsKatia Muller, Julie Kazimiroff, Mahnaz Fatahzadeh, Richard V. Smith, Mauricio J. Wiltz
The Journal of Infectious Diseases. 2015-02-13 - 10 citationsRemdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.Catharine I. Paules, Shannon K. Gallagher, Rekha R. Rapaka, Richard T. Davey, Sarah B Doernberg
Clinical Infectious Diseases. 2021-08-11 - 253 citationsDolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 StudyAntonella Castagna, Franco Maggiolo, Giovanni Penco, David Wright, Anthony Mills
The Journal of Infectious Diseases. 2014-08-01
Press Mentions
Paxlovid Use for COVID-19 May Be Feasible in Advanced CKDJuly 15th, 2022- Meningitis Vaccine May Guard Against GonorrheaApril 13th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
